<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table5" position="float"><label>Table 5.</label><caption><title>Proportions of responders within the groups of healthy and asthmatic participants, respectively.</title><p>Two different criteria were used in order to establish a statistically significant response. According to the first criterion, a participant is considered a responder with respect to a given biomarker if the outcome of comparing the pre-challenge time series and the post-challenge time series of the same biomarker by means of the Kolmogorov-Smirnov test results in a p-value&lt;=0.05 (columns 2 and 3). According to the second criterion, a participant is considered a responder with respect to a given biomarker if the outcome of comparing, by means of a Mann-Whitney-U-test, the magnitude of relative changes observed during 10 day time intervals prior to the challenge with the magnitude of relative changes that took place during 10 day time intervals that contained the day of the challenge results in a p-value&lt;=0.05 (columns 4 and 5). For calculating the proportion of responders within each group the p-values were corrected for multiple testing using the false discovery rate (FDR) method of Benjamini and Hochberg. FEV1: forced expiratory volume in one second. FVC: forced vital capacity. PEF: peak expiratory flow. FeNO: fractional expired concentration of nitric oxide. The lung function parameters FEV1 and FVC, and thereby their ratio FEV1/FVC, were normalized using the standardized reference equations recommended by Global Lung Function Initiative (GLI) Task Force for comparisons across different populations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Biomarker name</th><th valign="bottom">% Healthy responders (distributional changes)</th><th valign="bottom">% Asthmatic responders <break/>(distributional changes)</th><th valign="bottom">% Healthy responders <break/>(relative change within 10 days)</th><th valign="bottom">% Asthmatic responders <break/>(relative change within 10 days)</th></tr></thead><tbody><tr><td valign="bottom">PEF (% of predicted)</td><td valign="bottom">50.0%</td><td valign="bottom">75.0%</td><td valign="bottom">0.0%</td><td valign="bottom">0.0%</td></tr><tr><td valign="bottom">Normalized FEV1</td><td valign="bottom">75.0%</td><td valign="bottom">66.7%</td><td valign="bottom">0.0%</td><td valign="bottom">0.0%</td></tr><tr><td valign="bottom">Normalized FVC</td><td valign="bottom">83.3%</td><td valign="bottom">100.0%</td><td valign="bottom">0.0%</td><td valign="bottom">0.0%</td></tr><tr><td valign="bottom">Normalized FEV1/FVC</td><td valign="bottom">75.0%</td><td valign="bottom">66.7%</td><td valign="bottom">16.7%</td><td valign="bottom">0.0%</td></tr><tr><td valign="bottom">FeNO</td><td valign="bottom">8.3%</td><td valign="bottom">0.0%</td><td valign="bottom">41.7%</td><td valign="bottom">8.3%</td></tr><tr><td valign="bottom">Cell density in nasal lavage fluid</td><td valign="bottom">0.0%</td><td valign="bottom">0.0%</td><td valign="bottom">66.7%</td><td valign="bottom">41.7%</td></tr><tr><td valign="bottom">Neutrophils in nasal lavage fluid (%)</td><td valign="bottom">0.0%</td><td valign="bottom">0.0%</td><td valign="bottom">25.0%</td><td valign="bottom">16.7%</td></tr><tr><td valign="bottom">Eosinophils in nasal lavage fluid (%)</td><td valign="bottom">8.3%</td><td valign="bottom">0.0%</td><td valign="bottom">0.0%</td><td valign="bottom">16.7%</td></tr></tbody></table></table-wrap>